Loading clinical trials...
Loading clinical trials...
This study is to examine the safety, tolerability, pharmacokinetics and functional activity of ADC3680B administered once daily for 28 days in subjects with partly controlled atopic asthma.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pulmagen Therapeutics
NCT05660850 · Chronic Refractory Cough (CRC) With Non-atopic Asthma, CRC With Atopic Asthma, and more
NCT07114107 · Atopic Rhinitis, Atopic Asthma
NCT04728711 · Atopic Asthma
NCT04397081 · Human Papilloma Virus, Atopic Asthma, and more
NCT02748642 · Mild Atopic Asthma
Belfast
Manchester
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions